Atlas Trials

Hemoglobinuria, Paroxysmal

15 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Hemoglobinuria, Paroxysmal

RecordFirmDate
Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Subclinical Paroxysmal Nocturnal Hemoglobinuria and PNH in the Setting of Another Bone Marrow Failure Syndromes(PNH-2013) (NCT01760096)Institute of Hematology & Blood Diseases Hospital, China2013-01-01
Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Classic Paroxysmal Nocturnal Hemoglobinuria (NCT01642979)Institute of Hematology & Blood Diseases Hospital, China2012-07-01
Multicenter Retrospective Analysis About the Clinical Characteristics of Korean Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients (NCT01224483)Samsung Medical Center2010-08-01
Eculizumab Pharmacokinetics/Pharmacodynamics Study in Pediatric/Adolescent Paroxysmal Nocturnal Hemoglobinuria (PNH) (NCT00867932)Alexion Pharmaceuticals, Inc.2009-10-02
Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer (NCT00975975)Indiana University2009-09-01
Reduced Intensity Allogeneic PBSCT to Treat Hematologic Malignancies and Hematopoietic Failure States (NCT00997386)University of Arizona2009-09-01
Peripheral Blood Stem Cell Transplantation (PBSCT)From Haploidentical Related Donors (NCT00618969)University of Arizona2008-02-01
The Molecular Biology of Paroxysmal Nocturnal Hemoglobinuria (PNH) (NCT00721864)University of Utah2006-05-01
Identifying Characteristics of Bone Marrow Failure Syndromes (NCT00315419)Office of Rare Diseases (ORD)2006-04-01
Study of Safety in Hemolytic Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Treated With Eculizumab (NCT00122304)Alexion Pharmaceuticals, Inc.2004-12-01
Eculizumab to Treat Paroxysmal Nocturnal Hemoglobinuria (NCT00098280)National Heart, Lung, and Blood Institute (NHLBI)2004-12-01
Study Using Eculizumab in Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients (NCT00122330)Alexion Pharmaceuticals, Inc.2004-10-01
Stem Cell Transplantation for Patients With Hematologic Malignancies (NCT00152139)St. Jude Children's Research Hospital2002-05-01
The Paroxysmal Nocturnal Hemoglobinuria Early Access Treatment Protocol (NCT00438789)Alexion Pharmaceuticals, Inc.

Track Hemoglobinuria, Paroxysmal automatically

Every clearance here is in the API, with alerts when new ones post.